Wikidata

(Q43250016)

English

Bortezomib and high-dose melphalan as conditioning regimen before autologous stem cell transplantation in patients with de novo multiple myeloma: a phase 2 study of the Intergroupe Francophone du Myelome (IFM).

scientific article published on 2 November 2009

In more languages

Statements

title
Bortezomib and high-dose melphalan as conditioning regimen before autologous stem cell transplantation in patients with de novo multiple myeloma: a phase 2 study of the Intergroupe Francophone du Myelome (IFM) (English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
19884643
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19884643%20AND%20SRC:MED&resulttype=core&format=json
retrieved
11 February 2020
author
author name string

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q43250016&oldid=1858029831"